Compare RMBI & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RMBI | ACHV |
|---|---|---|
| Founded | 1887 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.3M | 172.0M |
| IPO Year | 2019 | 2018 |
| Metric | RMBI | ACHV |
|---|---|---|
| Price | $14.55 | $4.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.67 |
| AVG Volume (30 Days) | 44.0K | ★ 1.2M |
| Earning Date | 04-23-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.85% | N/A |
| EPS Growth | ★ 27.17 | N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $52.32 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.77 | $2.00 |
| 52 Week High | $16.04 | $6.15 |
| Indicator | RMBI | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 50.30 | 50.17 |
| Support Level | $13.05 | $4.65 |
| Resistance Level | $14.76 | $4.98 |
| Average True Range (ATR) | 0.31 | 0.42 |
| MACD | -0.08 | -0.11 |
| Stochastic Oscillator | 43.43 | 20.16 |
Richmond Mutual Bancorp Inc is a bank holding company. Along with its subsidiary, it is mainly engaged in attracting deposits from the general public, as well as brokered deposits, and investing those funds in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one- to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. It also obtains funds by utilizing Federal Home Loan Bank (FHLB) advances. These funds are generally invested in investment securities, including mortgage-backed and mortgage-related securities and agency and municipal bonds. The Group's primary market area includes Wayne and Shelby counties in Indiana and Shelby, Miami, and Franklin counties in Ohio.
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.